COLLABORATION AGREEMENTCollaboration Agreement • February 27th, 2007 • Exelixis Inc • Services-commercial physical & biological research • California
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24B-2 of the Securities Exchange Act of 1934, as amended.
COLLABORATION AGREEMENTCollaboration Agreement • February 27th, 2007 • Exelixis Inc • Services-commercial physical & biological research • Delaware
THIS COLLABORATION AGREEMENT (the “Agreement”) is made and entered into as of December 15, 2006 (the “Execution Date”) by and between EXELIXIS, INC., a Delaware corporation having its principal place of business at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083-0511 (“Exelixis”), and BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation headquartered at 345 Park Avenue, New York, New York, 10154 (“BMS”). Exelixis and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • February 27th, 2007 • Exelixis Inc • Services-commercial physical & biological research
THIS CONSULTING AGREEMENT (the “Agreement”) is made and entered into effective as of January 12, 2007 (the “Effective Date”) by and between EXELIXIS, INC., a Delaware corporation located at 170 Harbor Way, P.O. Box 511, South San Francisco, CA 94083-0511 (the “Company”), and JEFFREY LATTS, an individual whose address is as set forth on Exhibit A (“Consultant”).
